Zobrazeno 1 - 10
of 34
pro vyhledávání: '"E. Gentles"'
Autor:
Andrea N. Loes, Lauren E. Gentles, Allison J. Greaney, Katharine H. D. Crawford, Jesse D. Bloom
Publikováno v:
Viruses, Vol 12, Iss 9, p 987 (2020)
An effective vaccine is essential for controlling the spread of the SARS-CoV-2 virus. Here, we describe an influenza virus-based vaccine for SARS-CoV-2. We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in
Externí odkaz:
https://doaj.org/article/a81ba677af6b4bf286a8a79e248c7f43
Publikováno v:
Viruses, Vol 12, Iss 6, p 597 (2020)
Influenza virus infection elicits antibodies against the receptor-binding protein hemagglutinin (HA) and the receptor-cleaving protein neuraminidase (NA). Because HA is essential for viral entry, antibodies targeting HA often potently neutralize the
Externí odkaz:
https://doaj.org/article/4ce92a5e6e5a45a09b6697954cb75d22
Autor:
Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova, Matthew Angel, Javier G Magadán, Hang Xie, Christopher B Brooke, Jonathan W Yewdell
Publikováno v:
PLoS Pathogens, Vol 14, Iss 6, p e1007141 (2018)
[This corrects the article DOI: 10.1371/journal.ppat.1006796.].
Externí odkaz:
https://doaj.org/article/8ef0ef546f97472ab7d79fbed02fcebc
Autor:
Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova, Matthew Angel, Javier G Magadán, Hang Xie, Christopher B Brooke, Jonathan W Yewdell
Publikováno v:
PLoS Pathogens, Vol 14, Iss 1, p e1006796 (2018)
Rapid antigenic evolution enables the persistence of seasonal influenza A and B viruses in human populations despite widespread herd immunity. Understanding viral mechanisms that enable antigenic evolution is critical for designing durable vaccines a
Externí odkaz:
https://doaj.org/article/a8d6e151814b4d49b5ff844bb40bacbc
Autor:
Lauren E. Gentles, Leanne Kehoe, Katharine H.D. Crawford, Kirsten Lacombe, Jane Dickerson, Caitlin Wolf, Joanna Yuan, Susanna Schuler, John T. Watson, Sankan Nyanseor, Melissa Briggs-Hagen, Sharon Saydah, Claire M. Midgley, Kimberly Pringle, Helen Chu, Jesse D. Bloom, Janet A. Englund
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits an antibody response that targets several viral proteins including spike (S) and nucleocapsid (N); S is the major target of neutralizing antibodies. Here, we assess levels
Autor:
Lauren E Gentles, Leanne P Kehoe, Katharine D Crawford, Kirsten Lacombe, Jane Dickerson, Joanna H Yuan, Susanna L Schuler, Sankan Nyanseor, Sharon Saydah, Claire Midgley, Kimberly Pringle, Jesse Bloom, Janet A Englund
Publikováno v:
Open Forum Infectious Diseases
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits antibodies (Abs) that bind several viral proteins such as the spike entry protein and the abundant nucleocapsid (N) protein. We examined convalescent sera colle
Autor:
Jesse D. Bloom, Keara D. Malone, Lauren E. Gentles, Allison J. Greaney, Katharine H.D. Crawford, Tyler N. Starr, Andrea N. Loes, Helen Y. Chu
Publikováno v:
Sci Transl Med
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with mutations in key antibody epitopes has raised concerns that antigenic evolution could erode adaptive immunity elicited by prior infection or vaccination. The
Autor:
Keara D. Malone, Helen Y. Chu, Katharine H.D. Crawford, Jesse D. Bloom, Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, Tyler N. Starr
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
The emergence of SARS-CoV-2 variants with mutations in key antibody epitopes has raised concerns that antigenic evolution will erode immunity. The susceptibility of immunity to viral evolution is shaped in part by the breadth of epitopes targeted. He
Autor:
Christopher T. Stamper, Min Huang, Haley L. Dugan, Henry A. Utset, Jenna J. Guthmiller, Patrick C. Wilson, Florian Krammer, Julianna Han, Linda Yu-Ling Lan, Micah E. Tepora, Andrew B. Ward, Peter Palese, Siriruk Changrob, Nai-Ying Zheng, Jesse D. Bloom, Raffael Nachbagauer, Carole Henry, Olivia Stovicek, Shirin Strohmeier, Sara T. Richey, Li L, Lynda Coughlan, Adolfo García-Sastre, Dalia J. Bitar, Lauren E. Gentles
SummaryBroadly neutralizing antibodies against influenza virus hemagglutinin (HA) have the potential to provide universal protection against influenza virus infections. Here, we report a distinct class of broadly neutralizing antibodies targeting an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c917466d9dab820ce710a00d9d4ce230
https://doi.org/10.1101/2021.02.25.432905
https://doi.org/10.1101/2021.02.25.432905
Autor:
Allison J. Greaney, Jesse D. Bloom, Katharine H.D. Crawford, Lauren E. Gentles, Andrea N. Loes
Publikováno v:
Viruses, Vol 12, Iss 987, p 987 (2020)
Viruses
Volume 12
Issue 9
bioRxiv
article-version (status) pre
article-version (number) 1
Viruses
Volume 12
Issue 9
bioRxiv
article-version (status) pre
article-version (number) 1
An effective vaccine is essential for controlling the spread of the SARS-CoV-2 virus. Here, we describe an influenza virus-based vaccine for SARS-CoV-2. We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in